ANRO
ANRO
NYSE · Pharmaceuticals

Alto Neuroscience Inc

$30.76
+0.13 (+0.42%)
Analyst Consensus
Strong Buy
17
Analysts
High
Coverage
Buy 15 88%
Hold 2 12%
Sell 0 0%
Price Target
Analyst Price Target -27.9% upside
Low Target $14.63
Average Target $22.17
High Target $27.87
Current Price $30.76
Current
$30.76
Target
$22.17
$14.63 $22.17 avg $27.87
Scenario Analysis
Bear Case
$14.63
-52.4%
Low target
Base Case
$22.17
-27.9%
Avg target
Bull Case
$27.87
+-9.4%
High target
Risk/Reward
0.2x
Unfavorable
Price in Context
52-Week High
$37.48
-17.9% from high
52-Week Low
$3.59
+756.8% from low
Target vs 52W High
$22.17
-40.8% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%